About Rein Therapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.reintx.com/
Frequently Asked Questions
What is the 52-week range for RNTX?
The 52-week high is $2.18 and the 52-week low is $0.694.
What is the P/E ratio for RNTX?
The P/E ratio data is currently unavailable.
What is the dividend yield for RNTX?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -153.23%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.80.
Analyst Recommendation Trends
Wall Street analyst consensus for RNTX over the last few months:
Latest RNTX News
Stay updated with the stocks that are on the move in today's after-hours session.
After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress
AUSTIN, Texas, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis indications, today announced that it will present a late-breaking poster at the European Respiratory Society (ERS) 2026 Congress taking place September 5-9, 2026, in Barcelona, Spain. Poster Presentation Title: Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation s
Rein Therapeutics To Present Data On Inhaled LTI-03 For Idiopathic Pulmonary Fibrosis At European Respiratory Society 2026 Congress
Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis indications, today announced that it will present a
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-05-27 | VON RICKENBACH JOSEF H | +4,500 | $1.0708 | $4,819 |
| 2026-05-26 | VON RICKENBACH JOSEF H | +23,190 | $1.0552 | $24,470 |
| 2026-05-22 | VON RICKENBACH JOSEF H | +15,950 | $1.0475 | $16,708 |
| 2026-05-21 | VON RICKENBACH JOSEF H | +3,420 | $1.0422 | $3,564 |
| 2026-05-08 | WINDSOR JAMES BRIAN | -150,000 | - | - |
| 2026-04-30 | WINDSOR JAMES BRIAN | +25,000 | $1 | $25,000 |
| 2025-11-14 | Voss Advisors GP, LLC | +104,183 | $1.2247 | $127,593 |
| 2025-10-28 | Voss Advisors GP, LLC | +178,392 | $1.39 | $247,965 |
| 2025-10-27 | Voss Advisors GP, LLC | +4,840 | $1.3687 | $6,625 |
| 2025-10-27 | Voss Advisors GP, LLC | +92,642 | $1.37 | $126,920 |
| 2025-10-24 | Voss Advisors GP, LLC | +30,176 | $1.3904 | $41,957 |